Bank of New York Mellon’s Acer Therapeutics Inc ACER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,290
Closed -$9.5K 4423
2023
Q2
$9.5K Sell
10,290
-719
-7% -$637 ﹤0.01% 4346
2023
Q1
$8.35K Hold
11,009
﹤0.01% 4365
2022
Q4
$27.6K Sell
11,009
-66
-0.6% -$113 ﹤0.01% 4315
2022
Q3
$15K Hold
11,075
﹤0.01% 4479
2022
Q2
$14K Sell
11,075
-58
-0.5% -$121 ﹤0.01% 4526
2022
Q1
$32K Hold
11,133
﹤0.01% 4579
2021
Q4
$25K Hold
11,133
﹤0.01% 4574
2021
Q3
$29K Hold
11,133
﹤0.01% 4488
2021
Q2
$32K Sell
11,133
-1,573
-12% -$4.53K ﹤0.01% 4368
2021
Q1
$40K Sell
12,706
-1,020
-7% -$3.47K ﹤0.01% 4287
2020
Q4
$36K Hold
13,726
﹤0.01% 4175
2020
Q3
$40K Hold
13,726
﹤0.01% 4039
2020
Q2
$47K Sell
13,726
-7,753
-36% -$21.9K ﹤0.01% 3993
2020
Q1
$43K Buy
21,479
+10,721
+100% +$39.3K ﹤0.01% 3987
2019
Q4
$43K Buy
10,758
+605
+6% +$2.06K ﹤0.01% 4126
2019
Q3
$32K Sell
10,153
-621
-6% -$1.82K ﹤0.01% 4153
2019
Q2
$42K Buy
+10,774
New +$205K ﹤0.01% 4136
2017
Q3
Sell
-1,901
Closed -$13K 4318
2017
Q2
$13K Buy
+1,901
New +$12.6K ﹤0.01% 4257

Other funds holding ACER

Bank of New York Mellon's ACER Position: Q3 2023 in Review

Bank of New York Mellon sold out of Acer Therapeutics Inc (ACER) in Q3 2023, closing a stake of 10,290 shares — an estimated $9.5K sold.

Bank of New York Mellon first reported a position in ACER in Q2 2017 and held it in 18 quarters. The position peaked at $47K in Q2 2020. 31 funds tracked by Wall St. Rank hold ACER as of Q3 2023.

  • Bank of New York Mellon reported no remaining Acer Therapeutics Inc position as of Q3 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 10,290 Acer Therapeutics Inc shares in Q3 2023, an estimated $9.5K.
  • Bank of New York Mellon first reported a position in Acer Therapeutics Inc in Q2 2017 and held it in 18 quarters.
  • Bank of New York Mellon's Acer Therapeutics Inc position peaked at $47K in Q2 2020.
  • 31 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2023.

Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.